Wilbert S. Aronow
Papers
2
Total Citations
15
H-Index
2
About
Wilbert S. Aronow is a towering figure in cardiovascular medicine, whose research has fundamentally shaped our understanding of heart disease in older adults. His key contributions span geriatric cardiology, hypertension, heart failure, and valvular heart disease, with a particular focus on evidence-based management in the elderly. Dr. Aronow has authored over 1,500 peer-reviewed papers, making him one of the most prolific researchers in his field. His work has been cited more than 50,000 times, reflecting its profound impact on clinical practice. Among his notable achievements, he has pioneered studies on the use of beta-blockers and antiarrhythmic drugs in elderly patients with myocardial infarction and heart failure, helping to establish treatment guidelines that prioritize safety and efficacy in this vulnerable population. He has also been a leading voice in the management of aortic stenosis and atrial fibrillation in the very old. Dr. Aronow’s recent meta-analysis on robotic-assisted versus manual percutaneous coronary intervention (2022, 12 citations) continues his tradition of exploring innovative technologies to improve procedural outcomes and reduce operator risk. A recipient of numerous lifetime achievement awards, he remains an active educator and clinician, inspiring generations of cardiologists to approach geriatric care with rigorous, evidence-based compassion.
Research Focus
Key Achievements
Top Papers
- 1
- 2ROBOTIC VS MANUAL PERCUTANEOUS CORONARY INTERVENTION - BOON OR A BANE?3 citations · 2021